Pharmaceutical market access has evolved from a niche regulatory function into a central commercial discipline. In a landscape where payer coverage decisions can make or break a product launch, the teams responsible for securing formulary access carry enormous commercial weight. Yet market access teams are frequently among the leanest in a pharmaceutical organization — and in 2026, virtual assistants are helping them punch above their weight class.
The Payer Research Burden
Maintaining current intelligence on payer formulary policies, coverage criteria, and utilization management requirements across dozens of commercial and government payers is a continuous research function. Payer policies change quarterly. Step therapy requirements shift in response to competitive dynamics. Medicare and Medicaid coverage determinations affect access for large patient populations. Missing a policy change can result in prescribers encountering unexpected access barriers just as a product is gaining momentum.
Virtual assistants with structured research capabilities can monitor payer policy publications, track formulary updates from major national and regional payers, compile coverage requirement changes into accessible briefing formats, and maintain living payer landscape databases that market access managers can use to update field messaging and prior authorization support tools.
IQVIA's 2025 Payer Access Intelligence Report found that pharmaceutical companies with proactive payer policy monitoring capabilities detected coverage changes an average of 35 days earlier than companies relying on field-reported intelligence alone. For market access teams managing products in competitive therapeutic categories, that lead time is often the difference between maintaining prescriber confidence and experiencing a script decline that takes months to reverse.
Value Dossier and Formulary Submission Support
Value dossiers — comprehensive evidence packages supporting formulary access requests — are among the most document-intensive products a market access team produces. Assembling a dossier requires compiling clinical trial data, real-world evidence summaries, health economic analyses, comparative effectiveness data, and patient population epidemiology from dozens of source documents. The assembly and formatting work is substantial, even when the strategic content has already been developed by health economics and outcomes research (HEOR) teams.
Virtual assistants with document management experience can support dossier preparation by organizing source materials, formatting evidence tables, compiling references, maintaining version control across draft iterations, and coordinating review workflows between market access, medical affairs, and regulatory. McKinsey's 2025 Market Access Excellence in Biopharma report found that companies with dedicated administrative support for formulary submission preparation reduced average dossier development timelines by 28% without compromising scientific rigor.
For companies managing multiple formulary submissions simultaneously — a common scenario during product launches and label expansions — VA support for dossier administration can be the difference between a coordinated, on-schedule submission calendar and a chaotic backlog.
Payer Account Coordination
Market access managers maintain relationships with pharmacy and medical directors at major payers, regional plan account contacts, and integrated delivery network pharmacy leadership. These relationships require consistent communication management: meeting follow-ups, information request responses, contract document coordination, and escalation tracking for formulary petitions or coverage appeals.
Virtual assistants can manage the coordination layer of payer account relationships — scheduling meetings, preparing briefing materials, tracking outstanding information requests, coordinating internal approvals for payer commitments, and maintaining account activity logs in CRM systems. Veeva Systems' 2025 Payer CRM Benchmark data showed that market access teams with structured account activity tracking in CRM achieved 23% higher formulary win rates in contested payer reviews compared to teams with inconsistent CRM maintenance.
The coordination function is also critical for managing the interface between market access and the field sales organization. When payer coverage changes, field teams need rapid, accurate updates on how to respond to prescriber questions. VAs maintaining current payer intelligence and distributing it through structured field communication templates ensure that sales and access are aligned on the coverage landscape at all times.
PhRMA's 2025 Market Access Forum highlighted payer account coordination capability as an underinvested commercial function at many mid-sized biopharmaceutical companies — one that virtual assistant support models are well-positioned to address cost-effectively.
Pharma market access teams building out payer research and account coordination infrastructure should explore Stealth Agents for trained virtual assistants with life sciences market access experience.
Sources
- IQVIA, Payer Access Intelligence Report 2025, iqvia.com
- McKinsey & Company, Market Access Excellence in Biopharma 2025, mckinsey.com
- Veeva Systems, Payer CRM Benchmark Report 2025, veeva.com